Ireland
--:--IST
Recruiting Observational

Screening for Supportive Care Needs of Oncological Patients and Professionals - Evaluation of a Short PRO-question Set

NCT07505498 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2025-12-01
Last updated
2026-04-01

Condition(s) studied

Patient Related Outcome MeasuresSupportive CarePatient Reported Outcome (PRO)

Study summary

The systematic recording of patient-reported symptoms and health-related quality of life (patient-reported outcomes, PROs) is a central component of oncological care. Currently, however, screening for support needs in German hospitals is inconsistent and uses different assessment tools, leading to heterogeneity, redundant surveys, and limited comparability of results. This complicates standardized, patient-centered, and cross-sector care, as well as the early identification of therapy-associated side effects and support needs.

The aim of the study is to investigate the acceptance and relevance of the core set of questions from the perspective of both cancer patients and professional healthcare providers. Cancer patient acceptance will be measured by the proportion of fully completed questionnaires, while cancer patient relevance will be assessed using a feedback form. The professional perspective will be gathered through guided feedback in quality circles conducted regularly in accordance with internal standards

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years * Capacity to give consent * Cancer patients * Sufficient understanding of the German language Exclusion Criteria: * Minors * Lack of capacity to give consent * Insufficient knowledge of German

Primary outcome measure(s)

  • Proportion of Participants with Complete Core Question Set Completion at Baseline — Baseline
    Description Acceptance is operationalised as the proportion of enrolled cancer patients who fully complete the predefined Scope-PRO core question set at baseline. Questionnaire completeness is used as an indirect indicator of acceptability. Unit of Measure Proportion (%)
  • Participant-Reported Acceptance Score (Study-Specific Acceptance Feedback Questionnaire) at Baseline — Baseline
    Participant-reported acceptance is assessed using a study-specific feedback questionnaire evaluating comprehensibility, perceived burden, and overall acceptability of the core question set. Scale Study-specific Acceptance Feedback Questionnaire Range: 1 to 4 Higher scores indicate higher acceptance.

Trial sites (1)

FacilityCityRegionStatus
University Medical Center Göttingen, Department of Gastroenterology, gastrointestinal oncology and endocrinology Göttingen Germany Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07505498 on ClinicalTrials.gov ↗ ← All trials in Germany